Astrazeneca Plc stock is traded at $186.43, with a volume of 2,767,516. It is down -0.22% in the last 24 hours and up +17.54% over the past month. A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Previous Close:
$186.85
Open:
$181.34
24h Volume:
2,767,516
Relative Volume:
0.77
Market Cap:
$289.14B
Revenue:
$60.48B
Net Income/Loss:
$10.40B
P/E Ratio:
55.99
EPS:
$3.33
Net Cash Flow:
$8.05B
1W Performance:
-0.12%
1M Performance:
+17.54%
6M Performance:
+0.82%
1Y Performance:
+11.27%
1-Day Range:
$181.20$187.33
1-Week Range:
$181.20$192.65
52-Week Range:
$153.41$212.71
Astrazeneca Plc Stock (AZN) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS